Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis
BelgiumStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
The NetherlandsStudy on [68Ga]Ga-FAPI-46 PET/CT Imaging for Better Diagnosis in Patients with Pancreatic and Gastroesophageal Cancer
DenmarkStudy on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases
The NetherlandsStudy on Oral and Enema Fecal Microbiota Transplantation for Children with Ulcerative Colitis
FranceStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
BulgariaEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
BelgiumEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
BelgiumA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
GermanyThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
